Africa: The Gambia set to join the Banjul Protocol on Marks

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Africa: The Gambia set to join the Banjul Protocol on Marks

Sponsored by

spoor-fisher-400px.png
dan-roizer-gygpfmxgd1o-unsplash.jpg

Matthew Costard of Spoor & Fisher explains why the Gambia’s ‘British law’ legacy is a cause of concern for ARIPO trademarks

The African Regional Intellectual Property Organisation (ARIPO) is one of Africa’s two regional IP registration systems. ARIPO enables IP owners to get protection for their rights in one or more member countries through a central filing together with a designation of the countries of interest. This is in contrast to the African Intellectual Property Organisation (OAPI), which involves a single filing that automatically covers all the member countries.

The treaty that regulates ARIPO trademarks is the Banjul Protocol on Marks. Eleven countries can be covered through an ARIPO trademark registration (Botswana, Eswatini, Lesotho, Liberia, Malawi, Mozambique, Namibia, São Tomé and Príncipe, Uganda, Tanzania, and Zimbabwe).

On May 4 2021, ARIPO announced that the Gambia will be the 12th trademark member country, and will join the Banjul Protocol on Marks with effect from August 3 2021. What this means is that as of August 3 2021, trademark owners will be able to designate the Gambia in an ARIPO trademark application.

Yet trademark owners should be wary. The Gambia is what is sometimes known as a ‘British law country’. The effect of this is that international treaties do not become part of the Gambian law until such time as they are specifically enacted in local legislation. The Banjul Protocol on Marks has not been incorporated in any legislation in the Gambia, and this means that any designation of the Gambia in an ARIPO trademark application will have no effect. Purported trademark registrations will be open to attack.

It is worth noting that there is a draft law in the Gambia that does incorporate the Banjul Protocol into the Gambian law (An Act to Repeal The Industrial Property Act 2007, see Section 61(13)). It is not known when this will come into effect, although local sources are hopeful that the bill will be tabled at the next sitting of the National Assembly and that it will be enacted before August 3 2021. Until such a time when the draft law is in force, the safest course for trademark owners will be to use the national trademark system.

 

Matthew CostardDirector, Spoor & FisherE: m.costard@spoor.co.uk  

 

 

more from across site and SHARED ros bottom lb

More from across our site

The US decision marks a rare grant of a request under the Uniform Fraudulent Transfer Act in a patent case
Stobbs has applied to strike out a contempt of court application filed against the firm and two of its lawyers
With trademark volumes surging, trademark teams need to think beyond traditional clearance searches, towards a continuous, intelligence-led workflow, says Meghan Medeiros of Corsearch
Brazilian in-house counsel say law firms’ technology investments have not translated into tangible benefits, meaning tech use is a minor factor when selecting advisers
A lack of comfort among some salaried partners shows why law firms must actively foster inclusion, not merely focus on diversity mandates
Arrival of Laura Alonso, alongside a team of 11, will bring ‘significant value’ to ECIJA clients, says CEO
In the first of a two-part article, lawyers at Spruson & Ferguson and Marshall Gerstein provide an overview of China’s system for appealing against patent invalidation decisions
Lawyers and corporate leaders at INTA’s Business of M&A conference in New York discussed how cross-practice collaboration and early in-house involvement can help deals
Lily Li, partner at Morrison Foerster, shares how her litigation team helped secure victory at the ITC in a patent infringement case
Top talking points also included news of an appellate ruling concerning ‘Pisco’ and Indian drugmakers gearing up to launch generic versions of Ozempic as Novo Nordisk’s patent expires
Gift this article